Mohamad Z Koubeissi is a Washington, District Of Columbia based neurologist with 26 years of experience in Epilepsy Treatment. He completed his graduation in 1999. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Mohamad Z Koubeissi is MD040623 for Epilepsy Treatment in District Of Columbia. His current practice location is 2150 Pennsylvania Ave Nw # 9400, Washington. Patients can reach him at 216-280-9433. Mohamad Z Koubeissi is MD in Epilepsy Treatment and his NPI number (Unique professional ID assigned by NPPES) is 1548368970. Mohamad Z Koubeissi is focused on the diagnosis and treatment of patients with epilepsy, including new-onset, medically refractory epilepsy, psychogenic nonepileptic seizures, and epilepsy in special populations (the elderly, women, patients with co-morbidities). Epilepsy is a multidisciplinary field that provides comprehensive care of the patient.
Complete Profile:
Mohamad Z Koubeissi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Mohamad Z Koubeissi
Specialization:
Epilepsy Treatment
Gender:
Male
Credentials:
MD
Experience:
26+ years
Medical School Attended:
Other
Graduation Year:
1999
Accepts Medicare Assignment:
Yes
Practice Address:
2150 Pennsylvania Ave Nw # 9400, Washington, District Of Columbia, 20037-3201
Phone:
216-280-9433
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
9830194414
Enrollment ID:
I20120829000537
NPI Number:
1548368970
NPI Enumeration Date:
20 Sep, 2006
NPI Last Update On:
01 Apr, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mohamad Z Koubeissi are as mentioned below.
License Number
Specialization
State
Status
MD040623
Epilepsy Treatment
District Of Columbia
Primary
MD040623
Neurology
District Of Columbia
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(090001)
Washington, DC
Acute Care Hospital
(490050)
Arlington, VA
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Mohamad Z Koubeissi is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
George Washington University Medical Faculty Associates (4082528898)
590
Other Medical Identifiers:
Other legacy medical identifiers associated with Mohamad Z Koubeissi such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
1548368970
Other
Michigan
MICHIGAN MEDICAID
363721
Other
Ohio
WELLCARE MEDICAID
7796867
Other
Ohio
AETNA
2679874
Medicaid
Ohio
742962
Other
Ohio
BUCKEYE MEDICAID
000000216483
Other
Ohio
UNISON
1024173330001
Medicaid
Pennsylvania
P00440903
Other
Ohio
RAILROAD MEDICARE
000000510673
Other
Ohio
ANTHEM
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mohamad Z Koubeissi 2150 Pennsylvania Ave Nw # 9400, Washington, District Of Columbia
Zip:
20037-3201
Phone Number:
216-280-9433
Patients can reach Mohamad Z Koubeissi at 2150 Pennsylvania Ave Nw # 9400, Washington, District Of Columbia or can call to book an appointment on 216-280-9433.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.